register

News & Trends - Pharmaceuticals

Sun Pharma’s novel ophthalmic treatment now TGA approved

Health Industry Hub | February 11, 2020 |

Sun Pharma gains TGA approval of novel aqueous, nanomicellar ophthalmic ciclosporin solution, for treatment of moderate-to-severe keratoconjunctivitis sicca (dry eye), where prior use of artificial tears has not been sufficient.

CEQUA’s (ciclosporin 900 microgram/mL) novel delivery system, utilising nanomicellar technology, improves the formulation’s bioavailability and allows for a more than 10-fold increase in the aqueous solubility of ciclosporin.

According to leading Ophthalmologist from Vision Eye Institute, Associate Professor Colin Chan, Sydney, the TGA approval of an additional treatment option for dry eye disease will be welcomed by clinicians and patients alike, given the prevalence of the disease.

“Dry eye affects more than seven (7.4) per cent of the Australian population. The disease represents one of the most common reasons for seeking medical eye care, with a quarter of patients who visit ophthalmic clinics reporting symptoms of dry eye.

“Furthermore, one in five patients with dry eye are dissatisfied with their overall treatment due to lack of symptom relief, the time taken to relieve symptoms, and treatment side-effects,” said A/Prof Chan.

Ciclosporin is the first agent used in the treatment of dry eye to address the pathogenesis of the disease.

“The TGA’s approval of this novel treatment with improved solubility and tissue bioavailability, helps to fulfil a clinically unmet need for dry eye therapies especially for patients who don’t respond to previous therapies,” said A/Prof Chan.

CEQUA is a S4 product and requires a prescription. Sun Pharma is seeking PBS reimbursement for this product.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.